Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Farmers Insurance
Covington
Colorcon
UBS
Boehringer Ingelheim
Deloitte
Chubb

Generated: February 18, 2019

DrugPatentWatch Database Preview

ADVIL PM Drug Profile

« Back to Dashboard

Which patents cover Advil Pm, and when can generic versions of Advil Pm launch?

Advil Pm is a drug marketed by Pfizer and is included in two NDAs. There are three patents protecting this drug and two Paragraph IV challenges.

This drug has twelve patent family members in ten countries.

The generic ingredient in ADVIL PM is diphenhydramine citrate; ibuprofen. There are twenty-three drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the diphenhydramine citrate; ibuprofen profile page.

Summary for ADVIL PM
International Patents:12
US Patents:3
Applicants:1
NDAs:2
Suppliers / Packagers: 3
Bulk Api Vendors: 1
Formulation / Manufacturing:see details
DailyMed Link:ADVIL PM at DailyMed
Drug patent expirations by year for ADVIL PM

US Patents and Regulatory Information for ADVIL PM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer ADVIL PM diphenhydramine hydrochloride; ibuprofen CAPSULE;ORAL 021393-001 Dec 21, 2005 OTC Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Pfizer ADVIL PM diphenhydramine hydrochloride; ibuprofen CAPSULE;ORAL 021393-001 Dec 21, 2005 OTC Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pfizer ADVIL PM diphenhydramine citrate; ibuprofen TABLET;ORAL 021394-001 Dec 21, 2005 OTC Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for ADVIL PM
Drugname Dosage Strength RLD Date
➤ Subscribe Tablets 200 mg/38 mg ➤ Subscribe ➤ Try a Free Trial
➤ Subscribe Capsules 200 mg/38 mg ➤ Subscribe ➤ Try a Free Trial

International Patents for ADVIL PM

Country Document Number Estimated Expiration
Austria 309797 ➤ Try a Free Trial
Japan 2004521104 ➤ Try a Free Trial
European Patent Office 1363608 ➤ Try a Free Trial
Japan 2009203243 ➤ Try a Free Trial
Mexico PA03006364 ➤ Try a Free Trial
World Intellectual Property Organization (WIPO) 02056877 ➤ Try a Free Trial
Country Document Number Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Argus Health
Cerilliant
Mallinckrodt
Daiichi Sankyo
Cantor Fitzgerald
Chinese Patent Office
Express Scripts
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.